Switching Rat Resident Macrophages from M1 to M2 Phenotype by Iba1 Silencing Has Analgesic Effects in SNL-Induced

Roxana-Olimpia Gheorghe1, Andreea Violeta Grosu1, Melania Magercu1

  • 1Department of Anatomy, Animal Physiology and Biophysics, Faculty of Biology, University of Bucharest, 91-95 Splaiul Independentei, District 5, 050095 Bucharest, Romania.

Insights

Resident macrophages in dorsal root ganglia contribute to neuropathic pain. Silencing Ionized binding adapter protein 1 (Iba1) shifts these macrophages to an anti-inflammatory state, reducing pain and promoting nerve regeneration.

Area of Science:

  • Neuroscience
  • Immunology
  • Pain Research

Background:

  • Resident macrophages in dorsal root ganglia (DRG) play a crucial role in the development of neuropathic pain following nerve injury.
  • Ionized binding adapter protein 1 (Iba1) is a marker for macrophages and microglia, and Iba1-positive macrophages accumulate around DRG neurons after injury.
  • The early post-injury period presents a therapeutic window to investigate the role of resident macrophages in neuropathic pain.

Purpose of the Study:

  • To investigate the contribution of Iba1-positive macrophages in spinal nerve ligation (SNL)-induced neuropathic pain in rats.
  • To explore the potential of modulating macrophage phenotype from pro-inflammatory (M1) to anti-inflammatory (M2) via targeting Iba1.

Main Methods:

  • Intra-ganglionic injection of Iba1-siRNA in rats at the time of sciatic nerve injury (SNL).
  • Assessment of macrophage phenotype by analyzing M1 (CD32, CD86) and M2 (CD163, Arginase-1) markers.
  • Quantification of pro-inflammatory cytokines (IL-6, TNF-α, IL-1β) and pro-regenerative factors (BDNF, NGF, NT-3).
  • Evaluation of neuropathic pain and DRG neurite regrowth.

Main Results:

  • Iba1 silencing successfully shifted resident macrophages from an M1 to an M2 phenotype.
  • This phenotypic switch was confirmed by decreased M1 markers and increased M2 markers.
  • Reduced secretion of pro-inflammatory cytokines and increased release of neurotrophic factors were observed.
  • SNL-induced neuropathic pain was significantly reduced, and DRG neurite regrowth was initiated.

Conclusions:

  • Targeting the cytoskeleton protein Iba1 can modulate macrophage phenotype towards an anti-inflammatory and pro-regenerative state.
  • Modulating resident macrophage phenotype offers a potential therapeutic strategy for neuropathic pain.
  • This study demonstrates a novel approach to treat neuropathic pain by reprogramming macrophages.

Related Concept Videos